Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B

  • PDF / 342,239 Bytes
  • 1 Pages / 595.276 x 790.866 pts Page_size
  • 65 Downloads / 166 Views

DOWNLOAD

REPORT


RETRACTION NOTE

Retraction Note to: High‑dose therapy and autologous stem cell transplantation for relapsed or high‑risk diffuse large B‑cell lymphoma: a nationwide survey Sung‑Won Kim1 · Yoshitaka Asakura1,2 · Kinuko Tajima1 · Toshiki Iwai3 · Hirofumi Taji4 · Takaaki Chou5 · Yasuo Morishima6,7 · Junji Suzumiya8 · Hisashi Sakamaki9 · Ritsuro Suzuki8,10 · Takahiro Fukuda1

© Japanese Society of Hematology 2020

Retraction to: International Journal of Hematology (2020) 111:256–266 https​://doi.org/10.1007/s1218​ 5-019-02772​-1

Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Editor-in-Chief has retracted the original article following an investigation by the National Cancer Center Hospital that concluded that the research took place before ethical approval was given. All authors agree to this retraction.

The original article can be found online at https​://doi.org/10.1007/ s1218​5-019-02772​-1. * Sung‑Won Kim [email protected] 1



Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5‑1‑1 Tsukiji, Chuo‑ku, Tokyo 104‑0045, Japan

2



Department of Hematology and Oncology, Okinawa Chubu Hospital, Uruma, Japan

3

Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan

4

Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan

5

Department of Hematology and Oncology, Niigata Cancer Center Hospital, Niigata, Japan



6



Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan

7



Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

8



Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan

9



Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan

10

Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan

13

Vol.:(0123456789)